Yes it does...
It will be interesting to see what some of the analysts do with this.
A word of caution in that ISIS had a drug in the pipeline that may be a competing drug. Note these comments from a very knowledgeable poster on a private board that I follow.
Just so you know I have a lot of respect for this person as he has been proven right so many times in the past.
Here are his jetmanbash's quotes on the topic.
""""""""""""" As Dr. Crooke noted, ISIS Huntington's Disease drug is the only drug, so far, that hits the disease directly on the pathology target. So IMO, whatever the value of ASPX's drug, this drug from ISIS alone should/could be worth more. t
"""""""""""""